To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
LncRNA-targeting therapies for lung cancer
This project will develop and de-risk antisense oligonucleotide therapies targeting regulatory long noncoding RNAs in KRAS-mutated lung adenocarcinoma
Lead: Prof. Rory Johnson
